4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001140361-23-020315
Director sold 5,000 shares at $20.05 ($100,270)
- Director acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Chacko Jacob · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-21 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,000 | $9.41 | $47,050 | 5,000 | D |
| 2023-04-21 | Sale : show line 2 in the form 10b5-1 | −5,000 | $20.05 | $100,270 | 0 | D |
| Open-market sales · 5,000 sh · avg $20.05 · $100,270 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-21 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −5,000 | 32,500 | D |
Loading xslF345X04/form4.xml…